NCT00006011View on ClinicalTrials.gov

Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

659

Participants

Timeline

Start Date

July 31, 2000

Primary Completion Date

March 31, 2010

Conditions
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Endometrioid Adenocarcinoma, Variant With Squamous DifferentiationEndometrial Serous AdenocarcinomaStage III Uterine Corpus Cancer
Interventions
DRUG

Doxorubicin Hydrochloride

Given IV

DRUG

Cisplatin

Given IV

BIOLOGICAL

Filgrastim

Given SC

BIOLOGICAL

Pegfilgrastim

Given SC

DRUG

Paclitaxel

Given IV

Trial Locations (1)

19103

Gynecologic Oncology Group, Philadelphia

All Listed Sponsors
collaborator

Eastern Cooperative Oncology Group

NETWORK

collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00006011 - Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer | Biotech Hunter | Biotech Hunter